These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20966823)

  • 1. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
    Thobani A; Fishman GA
    Retina; 2011 Feb; 31(2):312-5. PubMed ID: 20966823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
    Genead MA; Fishman GA
    Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
    Andreuzzi P; Fishman GA; Anderson RJ
    Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors.
    Strong SA; Hirji N; Quartilho A; Kalitzeos A; Michaelides M
    Br J Ophthalmol; 2019 Feb; 103(2):233-237. PubMed ID: 29706600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Fiscella RG; Adelman AE
    Retina; 1997; 17(3):222-31. PubMed ID: 9196934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
    Fishman GA; Apushkin MA
    Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome.
    Lemos Reis RF; Moreira-Gonçalves N; Estrela Silva SE; Brandão EM; Falcão-Reis FM
    Ophthalmologica; 2015; 233(1):43-50. PubMed ID: 25428176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Giuffre G
    Am J Ophthalmol; 2006 Oct; 142(4):707; author reply 707-8. PubMed ID: 17011883
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
    Liew G; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis.
    Verbakel SK; van de Ven JP; Le Blanc LM; Groenewoud JM; de Jong EK; Klevering BJ; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5143-5147. PubMed ID: 27699410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cystic macular lesions in hereditary retinal dystrophies.
    Salvatore S; Fishman GA; Genead MA
    Surv Ophthalmol; 2013; 58(6):560-84. PubMed ID: 24160730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Apushkin MA; Fishman GA
    Am J Ophthalmol; 2006 May; 141(5):850-8. PubMed ID: 16546110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa.
    Chung H; Hwang JU; Kim JG; Yoon YH
    Retina; 2006 Oct; 26(8):922-7. PubMed ID: 17031294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
    Apushkin MA; Fishman GA; Grover S; Janowicz MJ
    Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.
    Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide.
    Schaal Y; Hondur AM; Tezel TH
    Can J Ophthalmol; 2016 Aug; 51(4):e113-e115. PubMed ID: 27521675
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa.
    Shimokawa S; Fujiwara K; Murakami Y; Funatsu J; Nakatake S; Yoshida N; Sonoda KH; Ikeda Y
    Ophthalmol Retina; 2020 Oct; 4(10):1036-1039. PubMed ID: 32454228
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.
    Karasu B
    Int Ophthalmol; 2020 Mar; 40(3):677-687. PubMed ID: 31773389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dorzolamide for patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA
    Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.